SciELO - Scientific Electronic Library Online

 
vol.34 issue4Economic evaluation of the introduction of 4CMenB (Bexsero®) in the national vaccine schedule in SpainAssociation between socioeconomic determinants and environmental tobacco smoke exposure in children author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Gaceta Sanitaria

Print version ISSN 0213-9111

Abstract

GIMENEZ, Emmanuel et al. Eleven years of economic evaluations of medical devices by the Spanish Network of Assessment Agencies. Methodological quality and cost-utility impact. Gac Sanit [online]. 2020, vol.34, n.4, pp.326-333.  Epub Feb 15, 2021. ISSN 0213-9111.  https://dx.doi.org/10.1016/j.gaceta.2019.06.010.

Objective

To analyse the quality and impact of cost-utility evaluations of medical devices carried out by the Spanish Network of Assessment Agencies (RedETS).

Method

The cost-utility evaluations of medical devices were identified by searching the evaluation reports of the RedETS website database (2006-2016). Quality and its impact were evaluated with a RedETS quality checklist, comparing cost-utility results and inclusion in the portfolio of common services of the National Health System. The portfolio inclusion status was analysed considering whether the cost-effectiveness incremental ratio was or was not less than €25,000/quality adjusted life years.

Results

25 cost-utility evaluations of medical devices were found (12 cost-utility, 10 cost-effectiveness and 3 both). Fifteen selected cost-utility studies with 19 cost-utility ratios met at least 18 of 25 verification criteria. Also, 12 of the 15 studies met 19 of the 25 criteria. On the impact, in 6 out of the 19 results, the product was included in the portfolio even though the ratio exceeded €25,000/quality adjusted life years. There are three cases undergoing a re-evaluation process, another case being reconsidered once the efficacy-safety of new devices has been reported and in two cases the portfolio states that protocols are required.

Conclusions

Most of the cost-utility evaluations of medical devices published by RedETS fulfil most of the items on the checklist and, therefore, were thorough. These cost-utility evaluations of medical devices are consistent with the decision-making framework to efficiently manage the National Health System portfolio.

Keywords : Efficiency; Medical devices; National portfolio; Cost-effectiveness; Health technology assessment; Economic evaluation.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )